Compare CVS & APO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVS | APO |
|---|---|---|
| Founded | 1963 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Investment Managers |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.7B | 85.5B |
| IPO Year | N/A | 2011 |
| Metric | CVS | APO |
|---|---|---|
| Price | $80.96 | $153.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 12 |
| Target Price | $92.11 | ★ $165.17 |
| AVG Volume (30 Days) | ★ 6.7M | 2.7M |
| Earning Date | 02-11-2026 | 02-03-2026 |
| Dividend Yield | ★ 3.31% | 1.36% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.37 | ★ 6.87 |
| Revenue | ★ $391,690,000,000.00 | $27,217,000,000.00 |
| Revenue This Year | $8.99 | N/A |
| Revenue Next Year | $2.77 | $34.62 |
| P/E Ratio | $216.91 | ★ $21.81 |
| Revenue Growth | ★ 6.66 | N/A |
| 52 Week Low | $44.92 | $102.58 |
| 52 Week High | $85.15 | $174.91 |
| Indicator | CVS | APO |
|---|---|---|
| Relative Strength Index (RSI) | 60.05 | 70.78 |
| Support Level | $78.22 | $144.16 |
| Resistance Level | $80.24 | $150.45 |
| Average True Range (ATR) | 1.37 | 2.79 |
| MACD | 0.24 | -0.23 |
| Stochastic Oscillator | 83.63 | 97.70 |
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Apollo is one of the world's largest alternative asset managers, with $908.4 billion in total assets under management, or AUM, including $685.0 billion in fee-earning assets, at the end of September 2025. The company has two core operating segments: asset management and retirement services. Apollo operates with scale in each of its major product lines—private equity (with $125.6 billion in total AUM and $71.7 billion in fee-earning AUM), real estate/real assets ($59.6 billion/$27.1 billion), and private credit ($723.2 billion/$586.2 billion). Apollo has a distribution profile that is likely not too far off from the industry averages—with 84% of its assets held by institutional investors and 16% by high-net-worth clients.